HHealth Read More Whanganui GP appointments, prescriptions, RAT sales swell as late flu surge enters springAugust 28, 2026 An intermediate school student she treated had influenza A for nine days, she said. Healthcare staff and their…
HHealth Read More Optimal prostate-specific antigen cutoff linked to improved prostate cancer survivalAugust 10, 2026 After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an…
HHealth Read More Integrated nanomaterials offer new strategies for cancer immunotherapyAugust 10, 2026 Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve…
HHealth Read More Wistar scientists develop new bispecific T cell engager to target ovarian cancerJuly 21, 2026 Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
HHealth Read More Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical studyJuly 14, 2026 A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory phase I…
HHealth Read More Memory B cells reveal how nasal vaccines could stop respiratory infections earlierJuly 7, 2026 New insights into lung-resident memory B cells show why the next generation of vaccines may need to protect…
HHealth Read More New breast cancer classification system predicts immunotherapy response successJuly 3, 2026 The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant…
HHealth Read More Imaging scans detect prostate cancer progression despite stable PSA levelsJuly 2, 2026 Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels…
HHealth Read More Engineered CAR T cells successfully target bladder cancer in miceJune 26, 2026 Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center, and Roswell Park Comprehensive Cancer Center have developed genetically engineered…
HHealth Read More Universal Sarbeco coronavirus vaccine proves safe in first human trialJune 5, 2026 The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and…
HHealth Read More PSMA PET detects high-risk prostate cancer bone metastasesJune 1, 2026 Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases…
TTechnology Read More Single-cell sequencing reveals why some CAR-T therapies succeed while others failApril 30, 2026 By mapping CAR-T cells one by one, researchers are uncovering the cellular traits that may separate durable cancer…